Injectable Drug Delivery Market Worth $1139.4 billion | ...
DoH Collaborates with Eli Lilly and World Obesity Federation ...
AVANCÉES DE LA RECHERCHE LORS DE LA ALZHEIMER'S ASSOCIATION ...
Regulatory T-cells Market to Observe Significant Growth ...
As Early-Onset Breast Cancer Cases Soar in North America ...
Cambrex anuncia un acuerdo estratégico con Lilly para apoyar ...
Day 1: News Alert: London Blockchain Conference 2024. London ...
Metastatic Prostate Cancer Market to Exhibit Positive Growth ...
Camurus and Lilly enter collaboration and license agreement ...
KeyBioscience Announces Extension of Strategic Collaboration ...
Medicilon nomme le Dr. Lilly Xu au poste de directrice de ...
Traumatic Brain Injury Market to Expand at a CAGR of 10.9% ...
Sleep Apnea Devices Market Size & Share to Surpass USD 20 ...
Triple-Negative Breast Cancer Market Gearing Up for Impressive ...
Pain Management Drugs Market to Reach $109.6 Billion Globally ...
Immunotherapy Drugs Market worth $580.6 billion by 2029 ...
Interstitial Cystitis Market to Grow Rapidly at a CAGR of ...
Untapped Potential: Antibody Discovery Market to Surge to ...
Prediabetes Market is Projected to Boost at a Moderate Growth ...
Medicilon nombra a la doctora Lilly Xu como directora de ...
Grünenthal announces acquisition of the rights to Cialis® ...
Cambrex gibt strategische Vereinbarung mit Lilly zur Unterstützung ...
Non-Hodgkin's Lymphoma Therapeutics Market to Reach USD ...
Rznomics Enters Global Licensing Agreement with Eli Lilly ...
Mild Cognitive Impairment Market is Predicted to Advance ...
Type 1 Diabetes Market to Accelerate Substantially During ...
Non-Insulin Therapies for Diabetes Market to Reach USD 58.6 ...
Oblique Therapeutics has entered a research collaboration ...
KeyBioscience kündigt Verlängerung der strategischen Zusammenarbeit ...
Radioligand Therapies Market to Show Immense Growth by 2034 ...
Abzena Announces Establishment of Scientific Advisory Board ...
FORSCHUNGSVORTSCHRITTE VON DER 2025 ALZHEIMER'S ASSOCIATION ...
Global Immunomodulator Market Valuation Set to Total a Staggering ...
High Potency Drug Market worth USD 379.20 Billion by 2031 ...
Hormone Replacement Therapy Market Size to Grow USD 18280 ...
KeyBioscience annonce l'extension de sa collaboration stratégique ...
GLP-1 Analogues Market Forecast: USD 471.1 Billion by 2032 ...
Fighting the Silent Killer: Innovative Therapies for Pancreatic ...
Radiopharmaceuticals Market to Reach $11.6 Billion by 2034 ...
Ovarian Cancer Drugs Market Size expected to reach US$ 4.23 ...
Cancer Care Disruptions Highlight Growing Demand for Innovative ...
Alchemab Therapeutics enters into collaboration with Lilly ...
Autoinjectors Market to Hit USD 3.02 Billion by 2030: Growth ...
Rising Number of Studies to Develop Novel Therapies For ...
Cambrex annonce un accord stratégique avec Lilly pour soutenir ...
Increase Prevalence of Diabetic Patients Driving Market ...
Cambrex Announces Strategic Agreement with Lilly to Support ...
Women's Health Market Size to Reach USD 130.9 billion 2031 ...
Beyond the Horizon: Innovative Drug Combinations Offer New ...
Alchemab Therapeutics signs landmark $415m licensing agreement ...
Metastatic HR+/HER2? Breast Cancer Market is Expected to ...
Rx-360® anuncia su junta directiva para 2024
Tirzepatida da Lilly promove perda de peso superior a semaglutida ...
Baricitinibe da Lilly proporcionou altas taxas de crescimento ...
Tirzepatida é superior ao placebo para tratar MASH e mais ...
Tratamento com tirzepatida em adultos com pré-diabetes ...
Eli Lilly do Brasil abre inscrições para programa de estágio ...
Conitec abre consulta pública para incorporação ao SUS ...
ANS abre Consulta Pública para avaliar incorporação de ...
ANS abre Consulta Pública para avaliar incorporação de ...
GLP-1 oral da Lilly orforglipron demonstra eficácia e segurança ...
Tratamento de dermatite atópica no SUS: CONITEC abre Consulta ...
Cambrex anuncia un acuerdo estratégico con Lilly para apoyar ...
Câncer de Pulmão e Tireoide: estudos apresentados no ESMO ...
Rx-360® anuncia o conselho de administração para 2024 ...
Chega ao Brasil medicamento que pode reduzir em 57% o volume ...
ANS abre Consulta Pública para avaliar incorporação de ...
Lilly do Brasil abre vagas para programa de estágio afirmativo ...
Anvisa aprova medicamento oral que pode reduzir o volume ...
Anvisa aprova primeira e única terapia-alvo para tumores ...
Cambrex anuncia acordo estratégico com a Lilly para apoiar ...
Clarivate Identifies Eleven Potential Blockbuster and Transformative ...
U.S. Institute of Peace Announces Three Finalists for 2024 ...
New York: Weitere Tech-Erholung bringt Nasdaq Rekordhoch ...
Eli Lilly enttäuscht mit Studie zu Abnehmpille - Ausblick ...
AKTIEN IM FOKUS 2: Abnehmpille bringt Eli Lilly unter Druck ...
Aktien New York Ausblick: Erholung dürfte weitergehen - ...
Eli Lilly enttäuscht mit Studie zu Abnehmpille - Ausblick ...
Eli Lilly enttäuscht mit Studie zu Abnehmmedikament - Jahresausblick ...
AKTIEN IM FOKUS: Pharmawerte unter Druck - Trump forderte ...
New York Schluss: Nach Rekorden ins Minus - Microsoft stark ...
AKTIEN IM FOKUS: Pharma unter Druck - Trump will günstigere ...
Trump will Pharmakonzerne zu günstigeren Preisen zwingen. ...
Novo Nordisk senkt wegen Konkurrenz Ausblick erneut - Aktie ...
EMA empfiehlt Zulassung von weiterem Alzheimer-Medikament ...
Übergewicht-Medikamente: So rasch nimmt man danach wieder ...
Nicola Mining beginnt mit langfristiger Gold- und Silberproduktion ...
WeightWatchers schließt finanzielles Restrukturierungsverfahren ...
Boris Becker über Nachwuchs: «Wird ein Weihnachtsgeschenk». ...
Interview mit Lilly Becker Jürgen Hingsen Franziska van ...
AKTIE IM FOKUS: Novo Nordisk fällt - Meinungen zu Cagrisema-Daten ...
New York Schluss: Verluste - Sorgen um Krieg in Nahost nehmen ...
Aktien New York: Verluste - wachsende Sorgen um Nahost-Entwicklung ...